P1534: SAFETY AND TOLERABILITY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS: A PHASE 1 PLACEBO-CONTROLLED SINGLE-DOSE STUDY

• J. Leu,
• A. Vermeulen,
• L. Ling

Affiliations

J. Leu

1 Janssen Research & Development, LLC, Spring House, PA, United States of America

A. Vermeulen

2 Janssen Research & Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium

L. Ling

3 Janssen Research & Development, LLC, Cambridge, MA, United States of America